Toronto Stocks Tumble; Aritzia Climbs Higher on 3Q Sales, Improved Fiscal Year Outlook
By Adriano Marchese
Stocks in Toronto were firmly lower mid-trading on Thursday in step with global markets. In the U.S., inflation climbed 0.3% in December from the prior month and increased 3.4% from a year earlier, at a higher rate than in November.
Most Canadian sectors were lower in the session, led by losses primarily in process industries, tech and utilities. Retail and energy were among the few gainers.
At midday, Canada's S&P/TSX Composite Index was down 0.95% to 20790.26 and the blue-chip S&P/TSX 60 fell by 1.03% to 1255.21.
Shares in Aritzia were nearly 20% higher at 31.72 Canadian dollars ($23.70) after the Canadian retailer reported higher sales in its fiscal third quarter, bucking the trend of a difficult retail environment, and narrowed its sales outlook for the full-year.
Other market movers:
Galaxy Digital Holdings said it has launched a bitcoin-focused exchange-traded fund with ETF-provider Invesco. Shares were 5.8% lower at C$10.32 after coming down from a high of C$12.40 earlier in the morning.
Endeavour Silver shares were 8.1% lower at C$2.38 after the company said it expects virtually unchanged production in 2024 and inflation-driven rising costs.
Solaris Resources' shares were 5.5% higher at C$4.22 after the company said it secure a C$130 million investment to support development of its flagship Warintza project in southeastern Ecuador.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 11, 2024 12:15 ET (17:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth